ImmuCell Corp (ICCC) stock

ICCCNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3016% above fair value

$10.22+0.03 (+0.29%)

Close on Nov 12, 2026Market cap $92.82MP/E 51.1Yield –

ImmuCell statistics

105 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 3, 2027 (estimated, after the close)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $92.82M; $280.48M
Enterprise Value: $92.80M; $148.62M
PE Ratio: 51.10; 24.95
PS Ratio: 2.79; 3.60
PB Ratio: 2.83; 2.05
P/TBV Ratio: 2.84; 2.29
P/FCF Ratio: 17.18; 18.26
P/OCF Ratio: 11.85; 12.93

Enterprise valuationIndustry

EV / Sales: 2.79; 2.60
EV / EBITDA: 13.31; 16.52
EV / EBIT: 19.32; 18.72
EV / FCF: 17.18; 22.07

Share statisticsIndustry

Shares Outstanding: 9M; 58M
Shares Change (YoY): 1.60%; 10.9%
Shares Change (QoQ): 0.09%; 0.51%
Float: 8M; 49M
Shares Held by Insiders: 13.6%; 12.1%
Shares Held by Institutions: 14.7%; 56.4%

Short sellingIndustry

Short Interest: 14,706; –
Short Interest Change: -18.8%; -0.76%
Short % of Float: 0.19%; 9.04%
Short % of Shares Outstanding: 0.16%; 6.30%
Days to Cover: 2.79; 5.13

Stock price statisticsIndustry

52-Week High: $12.10; –
52-Week Low: $4.52; –
20-Day Moving Average: $10.32; –
50-Day Moving Average: $10.09; –
200-Day Moving Average: $9.03; –
Average True Range (14): $0.33; –
Price Change (1 Week): 2.71%; 1.51%
Price Change (1 Month): -4.93%; -2.35%
Price Change (3 Months): 1.69%; -21.1%
Price Change (6 Months): 23.7%; -22.6%
Price Change (YTD): 66.2%; -22.6%
Price Change (1 Year): 63.0%; -20.7%
Price Change (3 Years): 96.5%; -27.4%
Price Change (5 Years): 10.8%; -77.3%
Price Change (10 Years): 98.1%; -62.7%
Average Volume (10 Days): 7,212; –
Average Volume (20 Days): 6,047; –
Average Volume (90 Days): 18,608; –
Relative Volume: 1.02; 0.79
Relative Strength Index (14): 50.1; 44.7
Volatility (1 Year): 50.6%; 80.4%
Beta (5 Years): 0.10; 1.07

MarginsIndustry

Gross Margin: 40.8%; 53.0%
Operating Margin: 14.5%; -38.7%
Pretax Margin: 5.79%; -11.8%
Profit Margin: 5.66%; -32.0%
EBITDA Margin: 21.0%; -27.7%
FCF Margin: 16.3%; -9.20%

Returns on capitalIndustry

Return on Equity (ROE): 6.01%; -51.2%
Return on Assets (ROA): 4.15%; -40.6%
Return on Invested Capital (ROIC): 13.8%; -32.9%
Return on Capital Employed (ROCE): 11.1%; -38.0%

Financial positionIndustry

Current Ratio: 4.61; 3.30
Quick Ratio: 2.41; 2.42
Debt / Equity: 0.24; 0.49
Debt / EBITDA: 1.13; 3.15
Debt / FCF: 1.46; 4.68
Net Debt / EBITDA: -0.00; 1.97
Interest Coverage: 12.19; -6.35

GrowthIndustry

Revenue Growth (YoY): 19.6%; 7.01%
Net Income Growth (YoY): -19.1%; -14.4%
EPS Growth (YoY): -23.1%; -11.7%
FCF Growth (YoY): 655.1%; 7.48%
Revenue Growth (3Y CAGR): 14.2%; 2.25%
Revenue Growth (5Y CAGR): 12.5%; 6.41%

EfficiencyIndustry

Asset Turnover: 0.73; 0.40
Inventory Turnover: 2.00; 2.73
Revenue Per Employee: $454.92K; $429.29K
Profits Per Employee: $25.75K; -$683.67K
Employee Count: 73; 75
WACC: 7.28%; 10.1%

Income statement (TTM)Industry

Revenue: $33.21M; $66.37M
Gross Profit: $13.56M; $116.10M
Operating Income: $4.80M; -$20.99M
Pretax Income: $1.92M; -$13.23M
Net Income: $1.88M; -$21.61M
EBITDA: $6.97M; -$16.85M
EPS (Diluted): $0.20; -$0.75

Balance sheetIndustry

Cash & Short-Term Investments: $7.91M; $67.63M
Total Debt: $7.90M; $116.91M
Net Cash (Debt): $15.56K; $17.46M
Net Cash Per Share: $0.00; $0.72
Equity (Book Value): $32.77M; $53.27M
Book Value Per Share: $3.61; $1.50
Tangible Book Value: $32.68M; $26.82M
Working Capital: $16.90M; $79.47M

Cash flow (TTM)Industry

Operating Cash Flow: $7.83M; -$12.27M
Capital Expenditures: -$2.43M; -$944.00K
Free Cash Flow: $5.40M; -$18.20M
FCF Per Share: $0.59; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 2.03%; -20.8%
FCF Yield: 5.82%; -9.58%
Buyback Yield: 0.00%; -0.73%
Shareholder Yield: 0.00%; 0.00%

Taxes and interestIndustry

Interest Expense: $394.01K; $2.93M
Income Tax: $44.54K; $74.00K
Effective Tax Rate: 2.31%; 20.9%

Scores and fair valueIndustry

Graham Number: $4.03; $19.34
Graham Upside: -60.6%; -46.9%
Altman Z-Score: 4.81; 0.30
Piotroski F-Score: 7; 4
Beneish M-Score: -3.10; -2.62

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	ICCC	S&P 500	Difference	ICCC per year	S&P 500 per year
1 month	+6.5%	-2.7%	+9.2 pts
3 months	-6.9%	-1.7%	−5.2 pts
Year to date	+66.2%	+11.9%	+54.3 pts
1 year	+66.7%	+12.0%	+54.7 pts
3 years	+89.3%	+78.2%	+11.1 pts	+23.7%	+21.2%
5 years	+10.8%	+73.2%	−62.4 pts	+2.1%	+11.6%
10 years	+98.1%	+309.6%	−211.6 pts	+7.1%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M ICCC shares were sold short on Oct 30, 2026, down 18.8% from the previous report, or 0.19% of the shares available to trade. At recent volumes it would take 2.8 days to buy them back. Over the last 20 sessions, 37.9% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	14,706	-18.8%	5,271	2.8
Oct 15, 2026	18,103	-18.1%	13,385	1.4
Sep 30, 2026	22,112	+11.5%	12,542	1.8
Sep 15, 2026	19,828	+2.9%	12,714	1.6
Aug 31, 2026	19,269	+26.6%	34,210	1.0
Aug 14, 2026	15,224	-13.5%	29,715	1.0
Jul 31, 2026	17,605	+25.3%	19,009	1.0
Jul 15, 2026	14,048	-24.9%	41,664	1.0
Jun 30, 2026	18,716	+52.4%	32,806	1.0
Jun 15, 2026	12,281	+35.1%	17,668	1.0
May 29, 2026	9,088	-12.9%	44,227	1.0
May 15, 2026	10,435	-42.6%	27,303	1.0